National University of Singapore opens new research institute in China to incubate medtech startups

The National University of Singapore (NUS) Guangzhou Research Translation and Innovation Institute (NUS GRTII), a collaboration between NUS, the People’s Government of Guangzhou Municipality, and the China-Singapore Guangzhou Knowledge City Administrative Committee, recently held the inauguration ceremony for its new building in Guangzhou, China.

The establishment of NUS GRTII, the university’s fourth overseas research institute in China, follows three other research institutes set up by NUS – the NUS Suzhou Research Institute, the Tianjin University-NUS Joint Institute in Fuzhou, and the NUS Chongqing Research Institute.

NUS GRTII has inked strategic collaboration agreements with 13 partners comprising leading Singapore enterprises, Huangpu District companies and other industry players and organisations.

One of the startups which will commence incubation at NUS GRTII is JN Medsys, an innovative Digital PCR technology company in Singapore, founded by Dr Johnson Ng. Another startup, Yimiji Technology, is an artificial inteligence (AI)-based medical image processing analysis platform and smart surgical robotic technology, enabling diagnosing and treating medical conditions during perioperative period.

In the area of education, NUS GRTII will train over 2,200 Chinese PhD and Master’s students, post-doctoral fellows as well as professionals over 10 years, supporting the Greater Bay Area with strategic talent development.